海普瑞 (002399)
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO.,LTD.
K-Line Chart
No K-line data available
Company NameShenzhen Hepalink Pharmaceutical Group Co., Ltd.
Listing Date2010-05-06
Issue Price148RMB
Registered Capital146729.620410k RMB
Legal RepresentativeLi Li
Registered AddressNo. 21 Langshan Road, Songpingshan, Nanshan District, Shenzhen, Guangdong Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, production, and sales of Heparin Sodium API.
Company ProfileShenzhen Hepalink Pharmaceutical Group Co., Ltd. produces Heparin Sodium API, which is exported globally to customers including world-renowned multinational pharmaceutical companies. Over the years, Hepalink has dedicated itself to the specialized field of Heparin Sodium product R&D and production, pioneering world-leading core process technology systems such as the "Impurity and Combination Separation Technology" and "Group Integrity Protection and Activity Release Technology" for Heparin Sodium. The company has established a comprehensive quality management system compliant with China's GMP standards as well as US and EU cGMP regulations and concepts. It is a major participant and standard provider in the revision of the United States Pharmacopeia standards.
Stock Details
1. Key Indicators
- Total Shares(W): 146729.62
- Circulating A-Shares(W): 124720.17
- Earnings Per Share(RMB): 0.3773
- Net Assets Per Share(RMB): 8.4302
- Operating Revenue(W RMB): 419446.44
- Total Profit(W RMB): 64159.91
- Net Profit Attributable to Parent(W RMB): 55357.57
- Net Profit Growth Rate(%): -29.04
- Weighted Return on Equity(%): 4.5100
- Operating Cash Flow Per Share(RMB): 0.9820
- Undistributed Profit Per Share(RMB): 2.8757
- Capital Reserve Per Share(RMB): 3.9964
2. Main Business
The main business covers:
- Heparin industry chain
- Biologics CDMO
- Investment, development and commercialization of innovative drugs
3. Company Basic Information
- Company Name: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Listing Date: 2010-05-06
- Industry: Pharmaceutical Manufacturing
- Address: No. 21 Langshan Road, Songpingshan, Nanshan District, Shenzhen City, Guangdong Province
- Website: www.hepalink.com
- Company Profile: The company was established as a joint-stock company through the overall restructuring of Shenzhen Hepalink Pharmaceutical Co., Ltd., approved by the Ministry of Commerce.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen Leren Technology Co., Ltd. | General Legal Person | 47402.99 | 38.01 |
| 2 | Gongqingcheng Jintiantu Investment Partnership (Limited Partnership) | General Legal Person | 40804.13 | 32.72 |
| 3 | Gongqingcheng Shuideshichuan Investment Partnership Enterprise (Limited Partnership) | General Legal Person | 4642.56 | 3.72 |
| 4 | Gongqingcheng Feilaishi Investment Co., Ltd. | General Legal Person | 4032.00 | 3.23 |
| 5 | Shenzhen Hepalink Pharmaceutical Co., Ltd. - Phase II Employee Stock Ownership Plan | General Legal Person | 1511.80 | 1.21 |
| 6 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1200.93 | 0.96 |
| 7 | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. - Phase III Employee Stock Ownership Plan | Asset Management Plan | 388.63 | 0.31 |
5. Concept Sectors
- H-Share
- Biological Vaccine
- CXO Concept
- Innovative Drug
- Margin Trading & Securities Lending
- MSCI Mid Cap
- Overseas Business
- Small Cap Value
- SZSE Value Index
- SME 300
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information